Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: A double-blind, randomized, placebo-controlled trial.

Osteoarthritis and cartilage·2026
Same author

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0.

Journal of extracellular vesicles·2026
Same author

SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain.

BMJ open·2026
Same author

Deprescribing in Older People: A Clinical Practice Guideline Summary.

The Medical journal of Australia·2026
Same author

Efficacy and Harms of Opioid Analgesics for Acute Pain: Overview of Systematic Reviews and Meta-analyses.

Drugs·2026
Same author

Urinary Δ<sup>9</sup>-tetrahydrocannabinol and metabolite concentrations following cannabis use: A systematic review.

Pharmacological research·2026

Related Experiment Video

Updated: May 9, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial.

Stephanie Mathieson1, Christopher G Maher, Andrew J McLachlan

  • 1The George Institute for Global Health and Sydney Medical School, University of Sydney, PO Box M201, Missenden Rd, Camperdown, Sydney, NSW 2050, Australia. clin@georgeinstitute.org.au

Trials
|July 13, 2013
PubMed
Summary
This summary is machine-generated.

This randomized trial investigates pregabalin for sciatica pain relief. Results will determine if pregabalin effectively reduces leg pain and is cost-effective for sciatica patients.

More Related Videos

Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:53

Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 15, 2024

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:26

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 8, 2024

Related Experiment Videos

Last Updated: May 9, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:53

Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 15, 2024

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
03:26

Targeted Muscle Reinnervation: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain

Published on: March 8, 2024

Area of Science:

  • Neurology
  • Pain Management
  • Clinical Trials

Background:

  • Sciatica is neuropathic pain causing leg and low back pain with potential neurological deficits.
  • Effective treatment options for sciatica are limited, impacting patient quality of life.
  • Current management challenges necessitate research into novel therapeutic strategies.

Purpose of the Study:

  • To evaluate the efficacy of pregabalin in reducing leg pain intensity in sciatica patients.
  • To assess the cost-effectiveness of pregabalin as a treatment for sciatica.
  • To investigate the impact of pregabalin on disability and quality of life.

Main Methods:

  • A double-blind, randomized, placebo-controlled trial (PRECISE) comparing pregabalin to placebo.
  • 102 participants randomized to pregabalin and 102 to placebo, with dosage up to 600 mg/day for 8 weeks.
  • Primary outcome: leg pain intensity reduction; secondary outcomes: back pain, disability, quality of life; follow-up to 52 weeks.

Main Results:

  • The study is designed to establish the efficacy of pregabalin in reducing leg pain intensity.
  • Secondary outcome analysis will provide data on pregabalin's effect on disability and quality of life.
  • Economic evaluation will determine cost-effectiveness from health sector and societal perspectives.

Conclusions:

  • This trial will determine pregabalin's effectiveness for sciatica leg pain.
  • Findings may inform the development of cost-effective conservative treatments for sciatica.
  • The study aims to improve clinical management and patient outcomes for sciatica.